Table 2

Comparative Evaluation of the Outcomes Post-TEVAR in Patients With AAD and CAD

OutcomeAAD (n = 29)CAD (n = 31)p Value
Major adverse events10 (34.4)4 (12.9)0.05
Lack of clinical success2 (6.9)0 (0)0.35
Mortality, 36 months4 (13.7)2 (6.4)0.35
Endoleak8 (14)5 (17)0.28
Major complications4 (14) (1 pseudoaneurysm of the left axillary artery; 2 retrograde extensions of the dissection; 1 temporary paraparesis)2 (3) (1 thoracic aortic aneurysm formation; 1 dissection of the left external iliac artery)0.35

Values are n (%).

TEVAR = thoracic endovascular aortic repair; other abbreviations as in Table 1.